-+ 0.00%
-+ 0.00%
-+ 0.00%

XORTX Therapeutics closes US$5 million follow-on offering at US$1.88/share

PUBT·05/19/2026 11:03:20
Listen to the news
XORTX Therapeutics closes US$5 million follow-on offering at US$1.88/share
  • XORTX Therapeutics closed a US$5 million public offering priced at US$1.88 per common share or pre-funded warrant.
  • Issued 183,577 common shares, issued 2,475,997 pre-funded warrants exercisable at US$0.0001 per share.
  • Net proceeds earmarked for working capital, general corporate purposes, investor relations activities.
  • E.F. Hutton received a US$200,000 cash commission, equal to 4%.
  • US$2.5 million of proceeds set to be paid to IR Agency LLC for marketing and advertising services.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XORTX Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-003522), on May 19, 2026, and is solely responsible for the information contained therein.